Moreover, oligorecurrent PCa represents a heterogenous group of men with different patterns of disease recurrence, including patients with biochemical persistence (BCP), BCR at first presentation, and further PSA recurrence after salvage therapies, who are in the late phase of the PCa natural history with a lower chance of being cured. This evidence concerns the gene BCR and posterior cortical atrophy.